Oral Drugs Targeting The Prostacyclin Pathway

Join Profs Gaine, Coghlan, and Humbert, as they discuss the rationale and process of adding oral drugs targeting the prostacyclin pathway for the treatment of PAH.


Prof. Gerry Coghlan
Consultant Cardiologist
Royal Free London NHS Foundation Trust

Prof. Sean Gaine
Consultant Respiratory Physician
Mater Misericordiae University Hospital, Dublin

Prof. Marc Humbert
Professor of Respiratory Medicine
South Paris University, Le Kremlin-BicĂȘtre, France

Relevant Societies

Supported with a hands off educational grant from Actelion